Physician profile
Vicky Luo
NPI 1568197838
$10,957.97
in general payments reported to CMS, 2019-2025
18 companies · $4,768 in 2025
The $4,768 reported for 2025 was more than what 99% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $324 · 2023: $2,445 · 2024: $3,422 · 2025: $4,768.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $10K · Education: $431.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,203.34 |
| Education | $430.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $2,623.41 | 2023-2025 | Tremfya |
| Incyte Corporation | $1,470.23 | 2022-2025 | Opzelura, Opzelura |
| Abbvie INC. | $931.13 | 2023-2025 | |
| E.R. Squibb & Sons, L.L.C. | $866.56 | 2022-2025 | Sotyktu |
| Genzyme Corporation | $835.58 | 2023-2025 | |
| Sun Pharmaceutical Industries INC. | $821.66 | 2022-2025 | Winlevi, Ilumya |
| Pfizer INC. | $564.28 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $548.56 | 2023-2025 | |
| Lilly USA, LLC | $516.34 | 2022-2025 | Taltz, Ebglyss, Olumiant |
| Dermavant Sciences, INC. | $369.99 | 2023-2024 | Vtama |
| Arcutis Biotherapeutics, INC. | $368.42 | 2023-2025 | Zoryve |
| Regeneron Healthcare Solutions, INC. | $293.57 | 2023-2025 | Dupixent |
| Galderma Laboratories, L.P. | $282.08 | 2024-2025 | Nemluvio |
| Organon LLC | $164.84 | 2025 | Vtama |
| Leo Pharma INC. | $161.03 | 2025 | Anzupgo, Adbry |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $87.52 | 2023-2025 | Bimzelx, Cimzia |
| Sanofi Pasteur INC. | $28.06 | 2024 | |
| Verrica Pharmaceuticals INC. | $24.71 | 2024 | Ycanth |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vicky Luo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.